Australian study provides insight into long-term efficacy of venetoclax in relapsed CLL

An extended follow-up on pooled data from four early-phase clinical trials of venetoclax in patients with previously treated CLL or small lymphocytic lymphoma has confirmed which patients are most likely to do well. The study, comprising 436 patients who had...

An extended follow-up on pooled data from four early-phase clinical trials of venetoclax in patients with previously treated CLL or...

Uncategorized

Specialist earnings – who are the winners & losers?

Incomes of rheumatologists and dermatologists have surged in recent years while endocrinologists and cardiologists have seen a decline in earnings, a new report shows. After adjusting for inflation, the majority of specialties experienced a real increase in hourly earnings between 2013...

Incomes of rheumatologists and dermatologists have surged in recent years while endocrinologists and cardiologists have seen a decline in earnings,...

Research

Decision fatigue erodes doctors’ judgement at the end of the day

Doctors’ clinical judgement worsens as the day progresses due to ‘decision fatigue’, a US study has found. To investigate how the time of day influences medical decision making, researchers looked at the rates of ordering of guideline-recommended cancer screening tests...

Doctors’ clinical judgement worsens as the day progresses due to ‘decision fatigue’, a US study has found. To investigate how...

Roundup lawsuits unlikely for Australian patients with non-Hodgkin lymphoma

Non-Hodgkin lymphoma patients who believe exposure to the herbicide glyphosate caused their disease are unlikely to win huge US-style legal damages claims, Australian lawyers say. Aside from doubtful scientific evidence linking glyphosate with haematological cancers, the Australian legal system does not...

Non-Hodgkin lymphoma patients who believe exposure to the herbicide glyphosate caused their disease are unlikely to win huge US-style legal...